Gmt Capital Corp Regenxbio Inc. Transaction History

Gmt Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $11.6 Million - $18.1 Million	-483,626 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$26.0 - $34.6 $10.8 Million - $14.3 Million	-414,441 Reduced 46.15%	483,626 $16.1 Million
Q3 2017 Nov 09, 2017	BUY	$18.0 - $32.95 $5.19 Million - $9.5 Million	288,367 Added 47.3%	898,067 $29.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	609,700	609,700 $12.3 Million

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $429M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Gmt Capital Corp with notifications on news.